+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antibodies"

From
Benlysta Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Benlysta Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
Tocilizumab Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

Tocilizumab Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
Androgenetic Alopecia - Pipeline Insight, 2026 - Product Thumbnail Image

Androgenetic Alopecia - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Mucopolysaccharidosis III - Pipeline Insight, 2026 - Product Thumbnail Image

Mucopolysaccharidosis III - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 60 Pages
  • Global
From
Bispecific Antibodies - Competitive Landscape, 2026 - Product Thumbnail Image

Bispecific Antibodies - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
From
From
From
From
From
From
Lupus Nephritis - Pipeline Insight, 2026 - Product Thumbnail Image

Lupus Nephritis - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 180 Pages
  • Global
From
Atopic Dermatitis - Pipeline Insight, 2026 - Product Thumbnail Image

Atopic Dermatitis - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 280 Pages
  • Global
From
Epidermolysis Bullosa - Pipeline Insight, 2026 - Product Thumbnail Image

Epidermolysis Bullosa - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 80 Pages
  • Global
From
SAPHNELO Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

SAPHNELO Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
RSLV-132 Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

RSLV-132 Sales Forecast and Market Size Analysis - 2034

  • Report
  • April 2026
  • 30 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2026

  • Report
  • January 2026
  • 400 Pages
  • Global
From
Monoclonal Antibodies - Competitive Landscape, 2026 - Product Thumbnail Image

Monoclonal Antibodies - Competitive Landscape, 2026

  • Report
  • January 2026
  • 450 Pages
  • Global
From
From
Loading Indicator

The Antibodies market is a subset of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Antibodies are proteins produced by the body to fight off foreign substances, such as bacteria and viruses. They are used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and cancer. Antibodies can be used in combination with other drugs, such as steroids, to reduce inflammation and improve symptoms. They can also be used to target specific cells or proteins in the body, allowing for more targeted treatments. The Antibodies market is highly competitive, with a number of companies offering a variety of products. Companies such as AbbVie, Amgen, and Biogen are leading the way in developing and marketing antibodies for the treatment of immune-related conditions. Other companies, such as Genentech and Regeneron, are also active in the market, offering a range of products for different conditions. Show Less Read more